These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22056993)

  • 41. Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.
    Gozzi A; Crestan V; Turrini G; Clemens M; Bifone A
    Psychopharmacology (Berl); 2010 Mar; 209(1):37-50. PubMed ID: 20111859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    McMahon LR; Filip M; Cunningham KA
    J Neurosci; 2001 Oct; 21(19):7781-7. PubMed ID: 11567068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.
    Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Hutson PH
    Psychopharmacology (Berl); 2009 Nov; 206(4):641-51. PubMed ID: 19707745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.
    Murnane KS; Guner OF; Bowen JP; Rambacher KM; Moniri NH; Murphy TJ; Daphney CM; Oppong-Damoah A; Rice KC
    Pharmacol Biochem Behav; 2019 Jun; 181():37-45. PubMed ID: 30998954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
    Benaliouad F; Kapur S; Rompré PP
    Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL; Wang RY
    Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of selective 5-HT1A receptor antagonists on regional serotonin synthesis in the rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan.
    Tohyama Y; Yamane F; Merid MF; Diksic M
    Eur Neuropsychopharmacol; 2001 Jun; 11(3):193-202. PubMed ID: 11418278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats.
    Wattiez AS; Pichon X; Dupuis A; Hernández A; Privat AM; Aissouni Y; Chalus M; Pelissier T; Eschalier A; Marin P; Courteix C
    PLoS One; 2013; 8(9):e74661. PubMed ID: 24058620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
    Mirjana C; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking serotonin 2A (5-HT
    Madden JT; Reyna NC; Goranson EV; Gonzalez TA; Zavala AR; Pentkowski NS
    Behav Brain Res; 2021 Oct; 415():113521. PubMed ID: 34391796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.
    Nic Dhonnchadha BA; Fox RG; Stutz SJ; Rice KC; Cunningham KA
    Behav Neurosci; 2009 Apr; 123(2):382-96. PubMed ID: 19331461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan(2).
    Yamane F; Okazawa H; Blier P; Diksic M
    Biochem Pharmacol; 2001 Dec; 62(11):1481-9. PubMed ID: 11728384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates.
    Murnane KS; Winschel J; Schmidt KT; Stewart LM; Rose SJ; Cheng K; Rice KC; Howell LL
    J Neurosci; 2013 Aug; 33(33):13367-74. PubMed ID: 23946394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
    Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
    Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5HT
    Amodeo DA; Rivera E; Cook EH; Sweeney JA; Ragozzino ME
    Genes Brain Behav; 2017 Mar; 16(3):342-351. PubMed ID: 27717169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.